Treace Medical Concepts (TMCI)

• Market cap: $357M
• 1 day: -3.41%
• 5 days: -2.58%
• 1 month: -18.77%
• 3 months: -28.59%
• 6 months: -24.40%
• Year to date: -27.95%
• 1 year: -5.50%
• 5 years: -77.79%
• 10 years: -77.79%
• Sector: Healthcare
• Industry: Medical Devices

About: Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Employees: 477

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1,452% more call options, than puts

Call options by funds: $388K | Put options by funds: $25K

16% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 25

13% more capital invested

Capital invested by funds: $278M [Q4 2024] → $315M (+$37.2M) [Q1 2025]

1% more funds holding

Funds holding: 135 [Q4 2024] → 137 (+2) [Q1 2025]

0.63% more ownership

Funds ownership: 59.88% [Q4 2024] → 60.51% (+0.63%) [Q1 2025]

9% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 45

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $8 41% upside
• Avg. target: $8.30 46% upside
• High target: $8.60 52% upside

2 analyst ratings

• positive: 0 0%
• neutral: 2 100%
• negative: 0 0%

UBS Danielle Antalffy	52% upside $8.60	Neutral Maintained	9 May 2025
Truist Securities Richard Newitter	41% upside $8	Hold Maintained	11 Apr 2025